Gatorade recalls 122,021 U.S. cases: what UAE pharmacies should check this week

PepsiCo has recalled 122,021 cases of Gatorade in 37 U.S. states after the U.S. Food and Drug Administration classified the action as Class II on 2 October 2026, according to the FDA enforcement notice reported by CBS News.

The immediate UAE risk is narrow because the FDA notice concerns U.S.-distributed 28-ounce bottles, not the 495ml Gatorade bottles commonly listed by UAE grocery retailers. The operational task is still real for Dubai clinics, sports medicine centres and pharmacies that buy imported beverages for waiting rooms, athlete hydration packs or resale. They need to check whether any U.S.-sourced stock entered local channels through parallel importers.

What was recalled

The affected products named in the FDA-linked report are Gatorade Lemon Lime, Gatorade Lemon Lime Zero, Gatorade Orange and Gatorade Orange Zero in 28-ounce bottles. The recall was initiated on 25 September 2026. The recall number is H-0009-2027. The issue is undeclared Yellow No. 5 and/or Yellow No. 6, rather than a bacterial contamination event.

“Class II” means exposure to a product may cause temporary or medically reversible adverse health consequences, or that the probability of serious adverse health consequences is remote. — U.S. Food and Drug Administration recall classification

PepsiCo’s recall sits inside a wider U.S. shift on synthetic food dyes. The FDA lists PepsiCo as having committed to remove FD&C colours from fruit punch, lemon lime and orange Gatorade Thirst Quencher and Gatorade Zero products in fall 2026, according to the FDA’s food dye pledge tracker.

Why UAE operators should care

For Dubai operators, the relevant local chain starts with Dubai Municipality for food safety and with the Dubai Health Authority (DHA) where a licensed healthcare facility is involved. Dubai’s Law No. 5 of 2025 gives the responsible food-safety entity powers over food traceability, withdrawal and recall, and requires food-related establishments to maintain traceability records and notify authorities where food poses a consumer-health risk.

Abu Dhabi and Al Ain providers should treat the same issue through the Department of Health Abu Dhabi (DOH) for licensed healthcare premises, while food product controls sit with the relevant emirate and federal food-safety channels. In Sharjah, Ajman, Ras Al Khaimah, Fujairah and Umm Al Quwain, healthcare licensing and pharmacy visibility connect to the Ministry of Health and Prevention (MOHAP) and federal pharmaceutical registers. Product recalls for defective consumer goods can also be reported through the UAE Ministry of Economy product recall service.

• Pharmacies and clinics should quarantine any U.S.-labelled 28-ounce Gatorade in the four named flavours until invoices, lot codes and supplier origin are checked.
• COOs should ask procurement teams for a same-day SKU list covering sports drinks, hydration products and patient refreshment stock.
• CFOs should expect a small direct inventory exposure: UAE retail listings show Gatorade-style 495ml bottles at about AED 4.99 at Carrefour UAE and about AED 5.95 on Noon, while venue prices can be higher.
• Medical directors should brief front desks that dye sensitivity complaints need clinical triage, not social-media reassurance.

What to do this week

The first step is to separate product size. A local 495ml bottle with UAE-compliant labelling is a different item from a U.S. 28-ounce bottle. The second step is supplier proof. Operators should ask distributors for country-of-origin records, batch information and any recall declaration covering the four named flavours. If a product was bought from a marketplace seller, staff should keep the invoice and product photographs before return or disposal.

Insurers such as Daman, Thiqa and Sukoon have no obvious reimbursement change from this recall. Their practical role is customer-service routing if a member reports symptoms after consuming imported stock. Clinics should document the product name, size, flavour, purchase source, date consumed and symptoms before deciding whether a physician visit, urgent care referral or simple product return is appropriate.

Patients should not rely on a U.S. recall headline to judge UAE shelf safety. They should check the bottle size, label language, importer details and purchase receipt. Pharmacies that receive questions should direct consumers to a licensed clinician if symptoms occur, and should use regulator channels where they identify suspect imported stock. For licensed pharmacy providers near a patient or clinic, use the UAE Open Healthcare Directory, which lists providers anchored to DHA, DOH and MOHAP licensing sources.